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Alternative
Tests Make
the Grade
Toxicity testing is absolutely nec-
essary for assessing the safety of
substances in food, air, and
water, in the workplace and at
home. Although there are several
tried-and-true toxicity assays, the
search is always on for methods
that can even better predict toxic
effects. As scientific understand-
ing of the effects ofenvironmental toxicants
grows, new tests are needed to evaluate previ-
ously unexamined end points and to take
advantage of advances in biotechnology and
the growing knowledge of how toxicants
work at the molecular and cellular levels.
Another issue is how to develop tests that can
reliably and accurately assess toxicity using
less time, money, and materials, and with
greater regard for animal welfare. The
Interagency Coordinating Committee on the
Validation of Alternative Methods (ICC-
VAM) was established in 1997 to address
these needs through the development, valida-
tion, acceptance, and harmonization of new
and revised toxicological test methods
throughout the federal government.
ICCVAM is made up of representatives
from the NIEHS and 13 other federal regula-
tory and research agencies. The National
Toxicology Program Interagency Center for
the Evaluation ofAlternative Toxicological
Methods (NICEATM, pronounced "nigh
SEE tum") was created in 1998 to support
ICCVAM's goals. NICEATM is housed on
the NIEHS campus in Research Triangle
Park, North Carolina. In collaboration with
ICCVAM, center staff review all nomina-
tions for assays to be evaluated and decide
whether there are sufficient data for an inde-
pendent public scientific peer review to pro-
ceed. NICEATM also assists in arranging the
peer review sessions and organizing the expert
panels and workshops. The center prepares
and publishes reports and information about
each validated test including a detailed
description of the methods and data used to
substantiate its validity. This information,
along with ICCVAM's recommendations on
the test's use, is sent to research and regulato-
ry agencies, which then decide whether and
how the method will fit into their program
activities.
The goal of ICCVAM is to facilitate the
scientific validation and regulatory accep-
tance ofnew test methods that are more pre-
dictive of human health and environmental
effects than current methods, and that will
reduce, refine, and replace animal use where
scientifically possible. Reduc-
tion means employing meth-
ods that use fewer animals
than standard historical mod-
els, or that obtain more types
of information from each ani-
mal. Refinement refers to
enhancing the animals' well-
being, for instance, by using
more humane end points to
end studies before the onset of
significant pain and distress.
Replacement can include
using nonanimal systems or
lower species (such as single-
celled organisms) in place ofhigherspecies.
Alternative methods also include in vitro
methods, such as cell cultures, and computer
technologies that allow scientists to use exist-
ing animal data to build predictive models.
Other alternative methods include transgen-
ics, toxicogenomics, proteomics, high
throughput technologies, molecular biomark-
ers, noninvasive imaging and labeling tech-
niques, and tissue engineering-all ofwhich
take advantage of recent advances in science
and technology.
Validation Projects to Date
Independent peer review panels are convened
to review each test method. These panels are
made up oftechnical experts from around the
world who have no financial investment in
the outcome of the review. Each panel must
reach a scientific consensus on the extent to
which the test method under review is useful
for predicting human and/or environmental
health effects. The panel must also identify
any limitations ofthe test method.
In reviewing each method, the peer
review panel considers two overall questions
in addition to a series ofdetailed test-specific
questions. First, has the method been evaluat-
ed sufficiently and is its performance satisfac-
tory to support its proposed use? And second,
has there been adequate consideration ofani-
mal welfare in terms of reduction, refine-
ment, and replacement? To date, ICCVAM
has completed reviews on two alternative test
methods-the murine local lymph node
assay (LLNA) and the Corrositex assay.
LLNA. The first peer
review panel evaluated
the LLNA in September
ove8. Already used for
over a decade to gauge
the potential ofchemicals
to cause allergic contact
dermatitis in a research
setting, the assay was recommended for full-
fledged endorsement as a viable stand-alone
test method.
Traditionally, guinea pig assays are used
to determine the potential of a chemical or
product to cause an allergic contact dermati-
tis response. Such assays involve the repeated
application of a test substance to the guinea
pigs' skin and examination ofthe site over 4
weeks to see whether an allergic response has
occurred or whether a delayed-sensitivity
response can be induced with additional
applications of the substance. While consid-
ered fairly reliable, these assays may produce
false positive and false negative results. In
addition, the results are somewhat subjective
and require considerable experience and
expertise to be accurately interpreted.
While the traditional assays measure the
allergic reaction itself, the LLNA measures
the lymphocyte proliferation response, a nec-
essary and inevitable biological precursor to
sensitization. In the LLNA, the test substance
is applied to the ears of4-5 youngadult mice
for 3 consecutive days. The animals are rested
for 2 days and then euthanized, and their
lymph nodes are removed and examined. If
the test substance spurs an immune response,
there will be a rapid proliferation of lymph
cells after the exposure. This measurable
increase in lymph cells can be used to charac-
terize the sensitization potential of the test
substance.
The peer review panel evaluated data on
209 chemicals. Of these, both LLNA and
guinea pig data were available for 126 chem-
icals, and both LLNA and human data were
available for 74 chemicals. From the data
submitted, the panel concluded that the
accuracy (the proportion of correct out-
comes) of the LLNA was about 86% when
compared to data from all guinea pig tests
and about 72% when compared to human
data (guinea pig tests have an accuracy of
about 73% compared to human data). In
terms ofaccuracy, sensitivity (the proportion
ofall test substances that are correctly classi-
fied as positive), specificity (the proportion
ofall test substances that are correctly classi-
fied as negative), positive and negative pre-
dictivity (the proportion ofpositive and neg-
ative test substances that are correctly identi-
fied by the assay as such), and comparability
to human data, the LLNA performs at least
as well as traditional guinea pig assays and in
some cases was a better predictor ofa human
allergic response. The LLNA was therefore
determined to be a viable alternative to tradi-
tional guinea pig assays for identifying strong
to moderate chemical sensitizing agents and
predicting the risk ofhuman allergic contact
dermatitis.
The LLNA offers many advantages over
traditional guinea pig assays. It allows scien-
tists to measure changes in allergic response
over several concentrations. Because the
method evaluates the induction phase rather
than the elicitation phase of the response,
the mice used in the LLNA don't suffer the
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tion. William Stokes, associate director for
animal and alternative resources in the
NIEHS Environmental Toxicology Program
and ICCVAM cochair, says, "The incorpora-
tion ofanearlier mechanistic end point in the
LLNA avoids virtually all pain and distress
that can occur in the traditional guinea pig
test. This test system is an excellent example
of an ideal humane end point." The LLNA
can also beperformed in a much shorterperi-
od oftime, at a lower cost, and with fewer
animals than thetraditional assays.
The main weakness identified was the
assay's prodivity toward false negative results
with some weak sensitizing agents and with
metals, and false positive results with some
strong irritants. Despite these limitations, the
peer review panel unanimously recommend-
ed the LLNA as a stand-alone alternative for
contact sensitization hazard assessment.
However, the panel did suggest some minor
standardization changes to the protocol. In
addition, because formal audited reports indi-
cating adherence to good laboratory practices
were not prepared for many ofthe validation
studies examined (the report notes this was
because the data were primarily intended for
publication), the panel suggested that retro-
spective data audits be conducted on at least
three of the validation studies conducted by
the sponsors.
Corrositex. In ^ January 1999, an
ICCVAM peer re-
* viewpanel evaluated
the Corrositex assay,
manufactured by
InVitro International of Irvine, California,
which is used to determinewhether achemical
will cause irreversible damage (corrosion) to
skin. Even before ICCVAM was established,
the U.S. Department ofTransportation had
accepted Corrositex as an assay for certain spe-
cificchemical dasses.
In the past, corrosivity ofchemicals and
chemical mixtures was determined by the
ability ofthe test substance to visibly damage
skin tissue-traditionally, that ofa rabbit-at
the site ofcontactwithin 4 hours ofexposure.
In the Corrositex method, a glass vial is filled
with achemical detection system consisting of
water and pH indicator dyes, and overlaid
with a collagen matrix membrane. Ifthe sam-
ple chemical penetrates the membrane, the
fluid will change color fromyellow to reddish
pink.
Before testing with Corrositex, all test
chemicals are prescreened by putting a small
amount of the test material directly in the
detection fluid. Ifthe material does not shift
the pH ofthe fluid to less than 4.5 or greater
than 8.5 and thereby change the color ofthe
detection fluid, itdoes notqualifyfor testing.
The panel reviewed Corrositex data firn
tests of 163 different materials for which
there were corresponding in vivo rabbit
corrosivity data. The panel confirmed
what the Department of Trans-
portation had already decided for
acids, bases, and acid deriva-
tives-that the test is useful as a
stand-alone assay. The panel
also concluded that Corrosi-
tex is useful as part of a
tiered assessment strategy for
testing those and other
chemical andproduct classes.
For acids, bases, and acid
derivatives, Corrositex had an
overall sensitivity of 90%, an
overall specificity of 70%, and
an overall accuracy of87%. The
main drawback the panel noted
was the proportion of test chemicals
that did not qualifyfor use with the test
(about 18%). Further review of the data
indicated, however, that the qualification
step eliminates primarily chemicals that are
noncorrosive, although some nonqualifying
chemicals mayactuallybe corrosive.
When used as a stand-alone assay for
identifying corrosives, Corrositex can replace
animal use altogether; when used as part ofa
tiered approach, it reduces and refines the
need for animal use by providing a basis for
decisions on whether further in vivo tests are
needed. When follow-up in vivo tests are nec-
essary, they may use fewer animals. Corrositex
also has the advantages ofbeing less expensive
than the rabbit skin test, displaying results
more quickly, and requiring no special equip-
ment, facilities, ortraining to use.
The panel recommended several minor
changes to the current test method protocol
in order to provide more detailed instructions
with the test kit and to address issues ofvari-
abilityin testingconditions.
What's Next
A workshop is planned for this May to assess
the validation status of the Frog Embryo
Teratogenesis Assay-Xenopus (FETAX), a
method used to evaluate the developmental
toxicity potential of chemicals. FETAX uses
early-stage embryos of the South African
clawed frog (Xenopus laevis) to measure the
effects ofchemicals on mortality, malforma-
tion, and growth inhibition. In July, a peer
review panel will review the validation ofa
revised version of the up-and-down proce-
dure, areduction alternative forthe tradition-
al LD50 test. And this fall there will be a
workshop to discuss currently available in
vitromethods forpredictingacutetoxicity.
In another project, ICCVAM and
NICEATM are working with the U.S.
Environmental Protection Agencyon the val-
idation ofscreening and testing methods for
endocrine disruptors. The center is also in the
process ofgathering background documenta-
tion on studies evaluating the use of trans-
genic mice to replace standard mice in car-
cinogenicity studies. These transgenic mice
are genetically engineered to be more suscep-
tible to developing cancer in response to
chemical carcinogens, allowing for studies
that can be performed in less time using
fewer animals.
Based on experience gained through
reviewing the LLNA and Corrositex, in
October 1999 ICCVAM revised the guide-
lines for stakeholders wishing to submit assays
for peer review. The new guidelines delineate
the type ofdata the committee will need to
evaluate a new or revised test method, and
include specifications for organizing the sup-
porting information so that the peer review
panel can morequicklyevaluate thevalidityof
a test method. Says Stokes, "We encourage
those involved in developing and validating
new test methods to use these guidelines dur-
ing the planning stages. This will increase the
likelihood thatdataneeded to characterize the
usefulness and limitations ofthe test method
will be generated. Itwill also increase the like-
lihoodthat therewill beadequateinformation
for agencies to make decisions on the accept-
abilityofthemethod." Thenew guidancewas
opened for public comment with a 2
December 1999 Federal Register notice.
Depending on the comments received, the
guidance may be revised further and reissued
laterthisyear.-Susan M. Booker
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